Association between nurse-led discharge planning and 30-day readmission: evidence from children with asthma
Published
June 22, 2026
Paper ID
PAP-000099
Status
Published
DOI
10.65712/tmj.test000357
Advance Services
Abstract
Background: The cost of 30-day readmission to health systems is substantial. Methods: Eligible participants were children with asthma. Results: The adjusted odds ratio was 0.64 (95% CI 0.41 to 0.72). Effects were consistent across prespecified subgroups. Conclusion: These findings suggest that nurse-led discharge planning is associated with better 30-day readmission in children with asthma.
Introduction
The cost of 30-day readmission to health systems is substantial. Earlier studies of nurse-led discharge planning were small or single-centre.
Practice around nurse-led discharge planning varies widely between centres. Earlier studies of nurse-led discharge planning were small or single-centre. 30-day readmission remains a leading cause of avoidable harm among children with asthma.
30-day readmission remains a leading cause of avoidable harm among children with asthma. The cost of 30-day readmission to health systems is substantial.
Discussion
Implementation will depend on staffing, cost and local protocols. Future work should test nurse-led discharge planning in a pragmatic multicentre trial.
Strengths include the sample size and blinded outcome assessment. These findings suggest that nurse-led discharge planning is associated with better 30-day readmission in children with asthma.
Conclusions
Nurse-led discharge planning should be considered for children with asthma to improve 30-day readmission.
References
1. Ahmed V, Yilmaz P, et al. A sepsis alert system and 30-day readmission. BMC Med. 2023;61(11):772-1522.
2. Larsen V, Haddad M, et al. High-flow nasal oxygen and health-related quality of life. Pediatrics. 2011;332(11):557-1657.
3. Kowalski J, Okafor S, et al. Early mobilisation and emergency department revisits. Crit Care Med. 2008;349(9):757-1170.
4. Ahmed K, Haddad K, et al. Vitamin D supplementation and in-hospital mortality. Diabetes Care. 2019;386(11):345-1705.
5. Kowalski Z, Moreau J, et al. Pharmacist-led medication review and in-hospital mortality. Lancet. 2020;144(12):629-1195.
6. Kowalski O, Okafor L, et al. Prone positioning and falls. Eur Heart J. 2020;253(12):711-1351.
7. Rossi F, Lindqvist I, et al. Low-dose aspirin and health-related quality of life. Pediatrics. 2017;212(1):724-1730.
Appendices
Supplementary tables are available on request.
Materials and Methods
Eligible participants were children with asthma. Missing data were handled with multiple imputation.
Missing data were handled with multiple imputation. The primary outcome was 30-day readmission, assessed blind to allocation.
We conducted a quality-improvement audit across 12 centres between 2015 and 2021. Missing data were handled with multiple imputation. Analyses were adjusted for age, sex and baseline severity.
Eligible participants were children with asthma. Missing data were handled with multiple imputation.
Results
943 participants were included (median age 37 years). Effects were consistent across prespecified subgroups. The adjusted odds ratio was 0.50 (95% CI 0.29 to 0.78).
Effects were consistent across prespecified subgroups. Serious adverse events were rare and similar between groups.
| Group | n | Events |
|---|---|---|
| Centre B | 334 | 23 |
| Age < 65 | 171 | 64 |
| Female | 259 | 84 |
| Male | 46 | 30 |
| Female | 350 | 12 |
| Age ≥ 65 | 302 | 12 |
| Centre B | 665 | 80 |
Values are n (%) unless stated otherwise.

Shown for children with asthma; error bars are 95% confidence intervals.

Shown for children with asthma; error bars are 95% confidence intervals.
Effects were consistent across prespecified subgroups. Serious adverse events were rare and similar between groups.